Aldeyra Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update

Go back to Aldeyra Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update

Aldeyra Therapeutics (ALDX) Reports In-Line Q2 EPS

August 8, 2019 7:13 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.49), in-line with the analyst estimate of ($0.49).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More